poisar

Stocks · News reference

Braveheart Bio IPO Indicating $25/Share On 304K Shares; IPO Priced At $18/Share

Aug 6, 2026, 2:37 PMBenzinga Newsdesk
Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

BRVE
Source
benzinga
Observed
Aug 6, 2026, 2:37 PM
Checked
Aug 6, 2026, 2:37 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 10, 2026, 7:20 PMBrendan Coffey

    Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors?

    Braveheart Bio Chairman Chris Viehbacher purchased 83,333 shares worth $1.5 million at the company's IPO price of $18 per share on August 7, 2026, expanding his direct stake by 16%. The insider purchase, combined with strong IPO demand and positive Phase 2 trial results for the company's lead cardiac myosin inhibitor candidate, signals bullishness around the clinical-stage biotech company.

    Read original at the-motley-fool
    BRVE